Mediator complex subunit 12 messenger RNA 3'-untranslated region (MED12 mRNA 3'-UTR)

The Mediator complex subunit 12 (MED12) messenger RNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the MED12 transcript that governs its stability and translation efficiency. As a component of the Mediator complex, MED12 plays a pivotal role in bridging transcription factors to the RNA polymerase II machinery, thereby regulating the expression of numerous genes involved in development and cell proliferation (UniProt Q93074). The 3'-UTR serves as a docking site for various microRNAs, such as miR-1 and miR-206, which post-transcriptionally downregulate MED12 expression (PubMed: 22431518). Dysregulation of MED12, often through mutations or altered expression levels, is a hallmark of uterine leiomyomas (fibroids) and has been implicated in the progression of prostate and breast cancers (PubMed: 21835992). Consequently, the MED12 mRNA 3'-UTR is considered a therapeutic target for RNA-based interventions, including microRNA mimics or antisense oligonucleotides, aimed at restoring normal MED12 levels. Targeting this region offers a precise method to modulate the Mediator complex's activity in oncogenic and proliferative disorders. However, therapeutic development must address challenges such as off-target binding and the essential role of MED12 in normal cellular homeostasis.

Other names

MED12 3'-UTRMediator complex subunit 12 3'-untranslated regionHOPA 3'-UTRKAUZ 3'-UTRTNRC11 3'-UTR

Modulation of protein expression through RNA interference or antisense-mediated degradation of the mRNA transcript.